INTRODUCTION
A physiologic role for the mucosal enzyme Na'-K+-activated adenosine triphosphatase (Na-K-ATPase) 1 in intestinal electrolyte absorption has been proposed (1, 2) . However, the relationship between the action of this enzyme and other intestinal enzyme systems believed to be involved in the transport of water and electrolytes (3. 4) has not been defined. One way of evaluating this relationship would involve the selective alteration and simultaneous measurement of these enzymes and their associated transport processes in the same segment of intestinal mucosa. It is well recognized that the intraluminal inoculation of cholera enterotoxin activates the intestinal adenylate cyclase-cyclic 3'5' monophosphate (cAMP) enzyme system and produces net secretion of water and electrolytes (3) (4) (5) . The recent finding that the parenteral administration of the glucocorticoid methylprednisolone acetate specifically enhances mucosal Na-K-ATPase activity and increases intestinal absorption of sodium and water (2) was significant in this regard since animals could now be exposed to agents known to stimulate intestinal absorption and secretion simultaneously. Our development of a reproducible model for cholera enterotoxin action in the rat ileum allowed us to (a) study the relationship of these enzyme and transport systems and (b) elucidate the mechanisms by which glucocorticoids inhibit cholera enterotoxin-induced intestinal secretion, an observation originally reported by Jacoby and Marshall (6) .
METHODS
Normal male albino Walter Reed rats2 weighing 250-350 g were maintained on a standard rat chow diet with free access to water. Each animal was anesthetized with sodium pentobarbital (6.5 mg/100 g), and two 15-cm ileal loops were constructed 5 cm apart beginning 40 cm proximal to the ileocecal valve. Each loop was inoculated with a total volume of 1.0 ml of either 0.9% saline or purified cholera enterotoxin dissolved in saline (choleragen) ( gg. After inoculation, the rats were allowed water for 2-18 h, after which the inoculum was washed out of each loop and intestinal transport studies were performed.
In one group of rats, an aqueous suspension of methyprednisolone acetate (Depo-Medrol, Upjohn Co., Kalamazoo, Mich.), 3 mg/100 g, was injected subcutaneously each day for the 3 days preceding inoculation. This dose and timecourse of methylprednisolone administration was shown to affect intestinal transport and Na-K-ATPase activity in our previous studies (2) . In another group of rats, a single injection of methylprednisolone acetate, 3 mg/100 g, was given 31 h after choleragen inoculation. A third group of rats was not treated with methylprednisolone.
Transport studies. Intestinal transport of electrolytes and water was measured by a modification of an in vivo perfusion technique previously described (8) . After washing with 50 ml of warm saline, both ileal loops were cannulated and perfused at a constant temperature (370C) and rate (0.5 ml/min) with a peristaltic pump (Harvard Apparatus Co., Inc., Millis, Mass., model 1203). Body temperature was maintained at 370C with a thermocouple-controlled heating lamp. Perfusion consisted of a 60-min steady state followed by three 20-min collection periods. The perfusion solution was a balanced electrolyte solution consisting of 140 mM Na, 5.2 mM K, 119.8 mM Cl, 25 mM HCO3, 1.2 mM Ca, 1.2 mM Mg, 2.4 mM HPO4, 0.4 mM H2P04, mannitol (to bring the final osmolality to 300 mosmol/l), and ["4C]polyethylene glycol (PEG) and unlabeled PEG (5 g/l) as a nonabsorbable marker. After the perfusion studies, the lengths of both ileal loops were measured in a uniform manner by one observer, and they were immediately prepared for enzyme analysis.
Net water and electrolyte transport was calculated as previously described (8, 9) (10) .
Samples of all ileal segments were placed in 10% formalin, stained with hematoxylin and eosin and periodic acid Schiff, coded, and examined by one of the authors. In preliminary studies, no effect of methylprednisolone or the perfusion studies on intestinal histology was observed. Enzinic assaivs. Mucosa was obtained from perfused ileal segments by scraping with a glass slide. One part of the mucosa was homogenized with a Teflon pestle and iced glass homogenizer in a solution containing 130 mM NaCl, 5 mM Na2EDTA, 30 mM imidazole, and 2.4 mM sodium deoxycholate (pH 6.8). The membrane-rich pellet obtained after successive centrifugations at 770 g and 10,000 g for 10 min at 0C (11) was assayed for Na-K-ATPase and Mgactivated ATPase activities as previously described (2, 12) . Approximately 100 ,ug of pellet protein was incubated for 15 min at 370C in a solution containing 100 mM NaCl, 20 mM KCI, 10 mM imidazole, 5.4 mM MgC12, and 5.4 mM disodium ATP (Grade II, Sigma Chemical Co., St. Louis, Mo.). The inorganic phosphate liberated was measured spectrophotometrically, and results were expressed as micromoles of inorganic phosphate liberated per milligram protein per hour.
Simultaneously, another part of the mucosal scrapings was homogenized with an iced sintered glass homogenizer in a solution containing 75 mM tris-(hydroxymethyl) aminomethane and 25 mM MgC12 (pH 7.6). The whole homogenate was assayed for adenylate cyclase activity by the method of Krishna, et al. (13) with minor modifications as previously described (2) . Approximately 50 ag of homogenate protein was incubated for 5 min at 370C in a solution containing 1.5 mM ATP, 1 /ACi (a-3'P) ATP (New England Nuclear, Boston, Mass.), 10 mM MgCI2, 10 mM theophylline, 30 mM tris-(hydroxymethyl) aminomethane, 5 mM phospho (enol) pyruvate, 50 jug/ml pyruvate kinase, and 20 jug/ml myokinase. After passage over columns of BioRad (AG50W-X4) resin (BioRad Laboratories, Richmond, Calif.), and alumina, radioactive cAMP in the eluate was measured in a Beckman Liquid Scintillation System LS-345. Appropriate corrections were made for incubations run without enzyme and for the incomplete recovery of cAMP. Results were expressed as picomoles cAMP formed per milligram protein per 5 min. Protein concentrations were determined by the method of Lowry et al. (14) .
In preliminary studies, no effect of the perfusion studies on ATPase or adenylate cyclase activity was noted, and whether choleragen was inoculated in the proximal or distal loop did not alter the effects of choleragen or methylprednisolone on enzyme activity or electrolyte transport.
Statistical analyses were performed by Student's t test for paired or unpaired data and were two tailed; linear regression analysis was by the method of least squares (15) . All results are expressed as the mean+SE. 
Choleragen-Induced Intestinal Secretion and Methylprednisolone

RESULTS
Effect of choleragen on rat ileum. Inoculation of rat ileal loops with choleragen at doses between 5 and 150 lg reproducibly affected ileal transport of water and electrolytes and mucosal adenylate cyclase activity (Table  I , Fig. 1 ). Water and electrolyte transport and enzyme activity in adjacent loops inoculated with 0.9% saline were unaffected. The levels of net water and electrolyte absorption observed in these saline-inoculated loops were similar to those previously reported from this laboratory (2) . 4 h after choleragen inoculation, all doses of choleragen decreased net water and Na transport in comparison with adjacent ileal loops inoculated with saline. Net secretion of water and Na occurred at choleragen doses at or above 25 lsg. Decreased net Cl absorption was seen in loops inoculated with 50 jug or more of choleragen. The minimal level of K secretion present in saline controls loops was significantly increased by all doses of choleragen between 5 and 150 l'g. The residual anion movement, probably representing net secretion of bicarbonate (10), also was enhanced by all choleragen doses. These changes in net water and electrolyte transport were all found to be linearly related to the dose of choleragen. The absolute level of net water transport decreased progressively with the dose of choleragen over the 5-150 ttg range (r = 0.91, slope = -0.08 Al/20 min per cm per jg, P < 0.01) ( Fig. 1 mid- dle panel). When the difference in net water movement between choleragen and saline-inoculated loops in each animal was plotted against choleragen dose, a linear relationship was again observed (r = 0.98, slope = -0.12, P < 0.01) ( Fig. 1 lower panel) . A similar linear relationship was found between choleragen dose and the absolute level of net Na movement (r = 0.89, slope = -0.02, P < 0.01), K movement (r = 0.91, slope = -0.001, P <0.02), Cl movement (r = 0.87, slope = -0.01, P < 0.05) and residual anion movement (r = 0.93, slope = -0.01, P < 0.01); and between choleragen dose and the difference in the movement of each ion between choleragen and saline-inoculated loops (Na: r = 0.90, slope = -0.02, P < 0.01; K: r = 0.98, slope = -0.001, P < 0.01; Cl: r = 0.71, slope = -0.01, P < 0.05; residual anion: r = 0.91, slope = -0.01, P < 0.01). Fig. 1 for 4 h value) . 5 ,ug of choleragen also produced a constantly decreased level of net water absorption between 31 and 7 h after inoculation (see 5 Ag dose in Fig. 1 for 4 h value) , although net secretion of water was not observed. However, 191 h after inoculation, 5 Ag of choleragen induced net secretion of water (-2.53±0.57 [8] vs. 5.45±0.84 [8] ,4/20 min per cm, P < 0.001) in conjunction with a decrease in the absorption of Na (-0.01+0.34 [8] Prevention of choleragen-induced ileal secretion by methylprednisolone. To determine the effect of methylprednisolone pretreatment on choleragen-induced intestinal secretion. methylprednisolone acetate, 3 mg/100 g, was injected each day for 3 days before loop inoculation. In ileal loops studied 4 h after inoculation with saline, both mucosal Na-K-ATPase activity and water absorption were enhanced in steroid treated as compared to untreated rats (Fig. 2) . Methylprednisolone pretreatment also enhanced Na and Cl absorption and K secretion, but did not affect residual anion secretion (Table II 2 Effect of methylprednisolone pretreatment on ileal enzyme activity and net water movement 4 h after choleragen inoculation. Choleragen increased adenylate cyclase activity (P <0.001) and caused net water secretion (P < 0.001) in untreated animals. In methylprednisolone treated as compared to untreated animals: saline inoculated loops had increased Na-K-ATPase activity (P < 0.001) and increased net water absorption (P < 0.001); choleragen inoculated loops had identically elevated adenylate cyclase levels and increased Na-K-ATPase activity (P < 0.005), and exhibited net water absorption ( creased mucosal Na-K-ATPase activity in these choleragen-exposed loops, and net absorption of water (Fig. 2) and Na (0.23+0.33 [10] vs. -1.25±0.41 [9] ueq/20 min per cm, P < 0.02) was observed. C1 absorption was greater and residual anion secretion was smaller in these choleragen-inoculated loops in methylprednisolone treated animals as compared to untreated animals, although these changes did not reach statistical significance (Table II) .
Of particular interest was the finding that the decrements in ileal water, Na, K, Cl, and residual anion movement produced by a 50 jg dose of choleragen 4 h after inoculation were very similar in untreated and methylprednisolone treated animals (Fig. 2, Table II) . Thus, the difference in water movement (-14.28±+1.34 ,Ll/20 min per cm) between choleragen (-3.57±+1.03 [9] ) and saline-inoculated loops (10.71+0.70 [9] ) in untreated animals was similar to the difference in water movement (-19.13±2.82 ,l/20 min per cm) between choleragen (4.46±0.99 [10] ) and saline-inoculated loops (23.59+2.15 [10] ) in methylprednisolone treated animals. The effect of choleragen on electrolyte movement (the difference between choleragen and saline-inoculated loops) in untreated and methylprednisolone treated animals was likewise remarkably similar (Na: -2.61±0.33 [9] vs. -2.36+0.30 [10] ; K: -0.12±0.02 [9] vs. -0.12 ±0.02 [10] ; Cl: -1.64±0.53 [9] vs. -2.17+0.58 [10] ; residual anions: -1.19±0.48 [9] vs. -0.30±0.41 [10] peq/20 min per cm). Apparently the effect of choleragen on ileal water and electrolyte movement, as on adenylate cyclase activity (Fig. 2) , is unaffected by methylpredniso- lone pretreatment and is independent of the initial level of net water and electrolyte movement.
To determine whether methylprednisolone pretreatment continued to prevent choleragen-induced ileal secretion beyond 4 h after inoculation, the effect of methylprednisolone 3 mg/100 g per day for 3 days, was examined in toxin-exposed loops 191 h after inoculation.
A 5-lcg inoculum of choleragen was chosen to avoid major histologic alterations (vide supra). However, the extended time period after loop inoculation did result in lower levels of water and Na absorption in the saline inoculated loops in untreated animals as compared to similar loops studied 4 h after inoculation (compare Fig. 3 and Table III with Fig. 1 and Table I ). Nevertheless, the 5-Ag dose of choleragen produced net secretion of water, and elevated levels of adenylate cyclase 19-. h after inoculation in untreated animals (Fig. 3) . Decreased absorption of Na and Cl and increased secretion of residual anions were also noted, although these changes were not statistically significant (Table III) . A positive sign indicates net absorption from the lumen, a negative sign net secretion into the lumen.
Choleragen-Induced Intestinal Secretion and Methylprednisolone Results are expressed as the mean-+SE. n indicates the number of animals studied. P values represent comparisons of saline and choleragen loops in individual animals (paired t test) and comparisons of methylprednisolone treated and untreated animals (unpaired t test). R represents net residual anion movement (JNa + JK -Jci). A positive sign indicates net absorption from the lumen, a negative sign net secretion into the lumen.
In methylprednisolone treated rats, saline-inoculated loops had enhanced mucosal Na-K-ATPase activity, and increased net water, Na and Cl absorption (Fig. 3 , Table III ). Choleragen-exposed loops in these methylprednisolone treated animals had increased adenylate cyclase and Na-K-ATPase activities and exhibited net water absorption (Fig. 3) . Net Na absorption and increased Cl absorption accompanied net water absorption in these choleragen-inoculated loops.
Reversal of choleragen-induced ileal secretion by methylpredn isolonie. While methylprednisolone clearly could prevent choleragen-induced intestinal secretion, it was also of interest to determine whether methylprednisolone could reverse this secretion once it had been initiated. In untreated animals, a significant decrease in ileal net water absorption (2.06±+1.32 [6] vs. 8.27±1.92 [7] 1l/20 min per cm, P < 0.01) was already present 31 h after exposure to 5 gg of choleragen as was an increase in residual anion secretion (-1.60±0.53 [6] vs. -0.80+0.28 [7] , P < 0.05) and K secretion (-0.06+ 0.20 [6] vs. -0.01±0.20 [7] , P < 0.05). Furthermore, activation of adenylate cyclase and net secretion of water and Na were still apparent in the ileal loops of these untreated animals 19-1 h after inoculation (Fig. 4 , Table   IV ). Since an increase in ileal Na-K-ATPase activity was apparent as early as 16 h after a single injection of methylprednisolone, 3 mg/100 g, (Fig. 4) , a single 3 mg/100 g dose of methylprednisolone was injected 3-1 h after inoculation of 5 mg of choleragen, and ileal transport and enzyme activity were measured 191 h after inoculation. As shown in Fig. 4 and Table IV , methylprednisolone reversed choleragen-induced ileal secretion of water, increased the net absorption of Na and Cl and reduced residual anion secretion. The change in water movement to net water absorption was highly significant (P < 0.005), and although the changes in electrolyte movement did not reach statistical significance, they mirrored the changes found 4 h (Table II) and 191 h (Table III) after choleragen inoculation in animals pretreated with methylprednisolone. In addition, both Na-K-ATPase and adenylate cyclase activities were increased at the time these measurements were made, 16 h after the methylprednisolone injection. In fact, neither activation of Na-K-ATPase nor reversal of cholerageninduced ileal secretion was observed earlier than 16 h after methylprednisolone treatment. The ability of methylprednisolone to overcome the effects of choleragen, thus, coincides with its enhancement of mucosal Na-KATPase activity, and is unaffected by prior activation of adenylate cyclase and the secretory process by choleragen. DISCUSSION These studies examined the effects of the glucocorticoid methylprednisolone on normal intestinal water and electrolyte transport and on choleragen-induced intestinal secretion. The increased ileal absorption of sodium and water after methylprednisolone administration, and the close association between these transport changes and the selective activation of Na-K-ATPase reported previously (2), were confirmed here. We also demonstrated that this glucocorticoid can modify the intestinal secretion induced by choleragen. Methylprednisolone 1596 A. N. Charney and M. Donowitz was able (a) when given before choleragen inoculation, to prevent choleragen from inducing intestinal secretion, and (b) when given after choleragen inoculation, to overcome the secretory effects of this enterotoxin. Since the transport changes induced by choleragen were accompanied and presumably mediated by activation of the single enzyme system adenylate cyclase (3-5, 16, 17) , the relationship between the Na-K-ATPase and adenylate cyclase enzyme system was also elucidated.
The use of paired ileal loops provided a convenient way to study the in vivo effects of both methylprednisolone and choleragen on intestinal transport and enzyme activity simultaneously. Differences tween two adjacent loops in an individual animal could be attributed to choleragen, whereas differences in similarly inoculated loops between methylprednisolone treated and untreated animals could be confidently attributed to niethylprednisolone. The ileum was studied because in preliminary experiments the effect of choleragen on jejunal water and electrolyte transport was less reproducible, and because in the rat, methylprednisolone exerts its maximum effect on water and electrolyte absorption in the ileum (2) . MAlethylprednisolone treatment enhanced Na-K-ATPase activity and net sodium, chloride and water absorption without significantly changing resi(lual anion movement in saline inoculated loops as early as 16 h after a single injection; these changes were still present 30 h after the last of three daily injections. In untreated animals, the loop inoculated with choleragen exhibited adenylate cyclase activation and net sodium and water secretion coincident with normal adenylate cyclase activity and sodium and water absorption in the adjacent saline-inoculated loop.
The lack of an effect on mucosal Na-K-ATPase activity by choleragen, previously reported in the rabbit (5), was also found in these studies in the rat. In addition to causing net sodium and water secretion, choleragen decreased the net absorption of chloride, and increased net residual anion (bicarbonate) secretion. The failure of choleragen to cause net chloride secretion was also reported in another in vivo cholera model (in the dog) (18) , and contrasts with choleragen-induced net secretion of chloride observed in vitro (3, 19, 20 Tables I and III) .
The prevention and reversal of choleragen-induced intestinal secretion by methylprednisolone were characterized by apparently independent alterations in (a) the processes of intestinal absorption and secretion, and (b) the Na-K-ATPase and adenylate cyclase enzyme systems which presumably mediate these transport processes. The activation of adenylate cyclase by choleragen Nvas not affected by pretreatment with methylprednisolone (or by the rise in Na-K-ATPase activity). In addition, methylprednisolone pretreatment did not affect the magnitude of the secretory effect of choleragen on water and electrolyte movement. Thus, the difference in water or sodium movement between choleragen and saline-inoculated loops in untreated animals (water: -14.28±1.34 t4/20 min per cm; Na: -2.61+0.33 ,ueq/20 min per cm) was similar to the difference in water or sodium movement between choleragen and saline-inoculated loops in methylprednisolone treated animals (water: -19.13+
2.82 p1/20 min per cm; Na: -2.36±0.30 ,/eq/20 min per cm). These data indicate that the effect of choleragen on ileal water and electrolyte transport was still apparent although net secretion was prevented by prior enhancement of Na-K-ATPase activity and the absorptive process by methylprednisolone. Similarly, the effects of methylprednisolone pretreatment on Na-K-ATPase and water and electrolyte movement were equally apparent in choleragen and saline-inoculated ileal loops. More importantly, these effects were apparent even when methylprednisolone was administered after the cholerageninduced secretory process had been initiated. These findings suggest that the prevention and reversal of choleragen-inducedl intestinal secretion by methylprednisolone reflect a balance between two independent and oppositelydirected transport processes. Accordingly, choleragen inoculation and parenteral methylprednisolone administration simply represent highly selective means of altering each of these processes. We are suggesting, then, that either the absorptive or the secretory process can predominate, depending upon, among other factors, the relative levels of Na-K-ATPase-associated intestinal absorption, and adenylate cyclase-associated intestinal secretion.
In addition to the close association between glucose independent intestinal sodium absorption and the level of nmtcosal Na-K-ATPase activity demonstrated previously (2) and confirmed here, there is evidence to suggest that the Na-K-ATPase enzyme system may play a role in gluLcose-dependent sodium transport (1).
Although the specific activity of Na-K-ATPase is unaffected by the presence of luminal glucose (2) , enhancement of intestinal glucose absorption and glucose-dependent sodium absorption by methylprednisolone in concert with increases in Na-K-ATPase activity was recently described (2) . Furthermore, ouabain, in serosal surface concentrations known to inhibit Na-K-ATPase activity (21) , decreased the mucosal-to-serosal flux of 3-O-methylglucose in the in vitro studies of Czaky and Hara (22) and prevented the increase in short circuit current which normally follows the addition of actively transported sugars (1) . Thus, sodium exit across the serosal surface of the intestinal epithelial cell may require Na-K-ATPase regardless of the mode of sodium entry across the luminal membrane (1). Our finding that the Na-K-ATPase enzyme system was unaffected by and acted independently of choleragen-induced intestinal secretion, then, may be relevant to several previous studies which showed that intraluminal glucose can overcome ongoing cholera enterotoxin-induced intestinal secretion both in vivo (23) (24) (25) and in vitro (19) . These studies have been interpreted as indicating that glucosedependent sodium absorption is intact during cholera enterotoxin-induced secretion. This interpretation was based, in part, on the finding that enhancement of sodium and water absorption by glucose was equally great in control and cholera enterotoxin-exposed intestinal mucosa (23) . Our finding that intestinal Na-K-ATPase is functionally intact in choleragen-exposed mucosa also supports this interpretation. Apparently, an intact intestinal Na-K-ATPase enzyme system is the basis for the integrity of both glucose-dependent sodium absorption andl methylprednisolone-stimulated glucose independent sodium absorption during cholera enterotoxininduced intestinal secretion.
To the extent that the effects of methylprednisolone lescribe(l here in rats can be extrapolated to humans, the mode of action of miiethylprednisolone in the treatment of diarrheal disease must be reexamined. An effect of glucocorticoids on human intestinal transport has been demonstrated indirectly (26) (27) (28) , although the efficacy, minimal dose required, and time-course of action have not been determined. Moreover, the ability of methylprednisolone to increase glucose absorption and glucose-dependent as well as glucose independent intestinal Na absorption suggests that it may have even greater effects under optimal clinical conditions than we could demonstrate in rats in the absence of luminal glucose. Not withstanding these clinical implications, we believe the interactions of methylprednisolone and cholera enterotoxin described here will provide other insights into the mechanisms of intestinal electrolyte transport.
